Blog

<p>The immediate access to safety data and project metrics is a key benefit for a complex study like ours.</p>

Traditional Phase II Oncology Trials Just Don't Cut It

A recent article (originally appearing in Oncology NEWS International Vol. 18 No. 12) discusses traditional Phase II trials for oncology and whether or not they should be phased out. The author... Read more

Discussing a new model for global research with Applied Clinical Trials

We recently got a chance to chat with Applied Clinical Trials’ Lisa Henderson about our new network approach to global clinical development. Coming face to face with breaking industry... Read more